News LCT AGM told of strong progress in 2005 The Chairman of Living Cell Technologies (ASX:LCT), Mr Michael Yates, told today's Annual General Meeting that the company had made strong progress throughout the last 12 months and was now looking forward to securing approval for phase I clinical trials of its NeurotrophinCell product. Related Document |